Innoviva (INVA) Assets Average (2011 - 2026)
Innoviva (INVA) posted Assets Average of $1.7 billion for Q1 2026, up 13.3% on a QoQ basis from $1.5 billion in Q4 2025, and up 35.86% year-over-year from $1.3 billion in Q1 2025.
Innoviva (INVA) Assets Average (2011 - 2026) Analysis & Trends
Innoviva's Assets Average history runs 16 years deep, the most recent figure standing at $1.7 billion for Q1 2026.
- Quarterly Assets Average rose 35.86% year-over-year to $1.7 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.7 billion (up 35.86% YoY) and the FY2025 annual result came in at $1.5 billion, up 20.99% from the prior year.
- Assets Average was $1.7 billion for Q1 2026 at Innoviva, up from $1.5 billion in the prior quarter.
- Across five years, Assets Average topped out at $1.7 billion in Q1 2026 and bottomed at $1.0 billion in Q1 2022.
- A 5-year average of $1.3 billion and a median of $1.2 billion in 2024 frame the typical range for Assets Average.
- Annual changes were most pronounced in 2022 — Assets Average surged 47.06% — and 2023, when it dropped 6.45%.
- Innoviva's Assets Average stood at $1.3 billion in 2022, then slipped by 4.99% to $1.2 billion in 2023, then increased by 4.16% to $1.3 billion in 2024, then increased by 20.99% to $1.5 billion in 2025, then climbed by 13.3% to $1.7 billion in 2026.
- Business Quant data shows INVA's Assets Average at $1.7 billion in Q1 2026, $1.5 billion in Q4 2025, and $1.4 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 303.40 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 65.01 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 8.37 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 41.64 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 26.06 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 40.71 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 795.91 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 2.30 Bn |
| 10 | Innoviva | 1.57 Bn | 969.11 Mn | 75.83 Mn | 1.74 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.74 Bn |
| Dec 31, 2025 | 1.53 Bn |
| Sep 30, 2025 | 1.38 Bn |
| Jun 30, 2025 | 1.29 Bn |
| Mar 31, 2025 | 1.28 Bn |
| Dec 31, 2024 | 1.27 Bn |
| Sep 30, 2024 | 1.23 Bn |
| Jun 30, 2024 | 1.25 Bn |
| Mar 31, 2024 | 1.26 Bn |
| Dec 31, 2023 | 1.22 Bn |
| Sep 30, 2023 | 1.15 Bn |
| Jun 30, 2023 | 1.12 Bn |
| Mar 31, 2023 | 1.18 Bn |
| Dec 31, 2022 | 1.28 Bn |
| Sep 30, 2022 | 1.23 Bn |
| Jun 30, 2022 | 1.12 Bn |
| Mar 31, 2022 | 1.02 Bn |
| Dec 31, 2021 | 906.82 Mn |
| Sep 30, 2021 | 838.19 Mn |
| Jun 30, 2021 | 938.72 Mn |